Randomized Clinical Trial Of Bococizumab (PF-04950615; RN316) In Subjects With Hyperlipidemia Or Mixed Dyslipidemia At Risk Of Cardiovascular Events

NCT01968954 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
711
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer